SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
BINX: Incredible Product
An SI Board Since June 1997
Posts SubjectMarks Bans Symbol
103 2 0 BINX
Emcee:  Howard Type:  Unmoderated
BINX: Bionix Implants markets to orthopaedists, urologists, etc.
As an orthopaedist we first saw their product 3 mos ago at our largest national meeting. Few people had actually used the product by then. The product is called an Arrow and allows us to FIX the meniscal cartilages in the knee joint. Before this product came out very few orthopaedists had the skill to do so, and even if you did, it added at least 30 minutes to your procedure time and required an additional incision. Now with these arrows, it takes less than 5 minutes and everyone can do it !!! At our hospital alone, and we perform the second highest number of these surgeries in NYC, the use of the Arrow has increased over 500%. This product is incredible. It is fast, easy and PROPRIETARY, there is nothing else like it out there. This product alone, I believe will propel this stock forward for a while. As of their last quarter, very few people were using it and they still had > 100% increases in various numbers, I can not imagine what the numbers will be now. the rep we ask to bring the equipment into the hospital says he can't keep it on the shelves and as per the CFO they recently tripled their previous capacity.

Earing will be out mid July. the chart may be a little over-extended, but that's not what's driving this stock.

Check it out and see if you agree.
HJLmd
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
103 << I plan to enter somewhere down the road.>> What will your entrEve Edelson-5/3/1998
102 May, 1998 issue of Individual Investor magazine has a very positive story on BTimothy Kross-5/2/1998
101 FDA marketing approval obtained. Mel Spivak-3/31/1998
100 Hi; Is this competition "carticel" from GENZL? Thanks; SteveSteve Lokness-3/11/1998
99 Howard or any orthopedists who can comment on BINX's new competition? How James Baker-3/9/1998
98 BINX announced that they now have competition that will slow sales of Meniscus Mel Spivak-3/9/1998
97 Howard, (or anyone else): post #2 indicated you thought less than 5% of the surJerryR-2/22/1998
96 Get ready for the upsurge. There was a pullback following the excitement from tMel Spivak-2/17/1998
95 That was a great article! I can hardly wait for tommorrow's action. marcSparticus-2/1/1998
94 Today's IBD New America has very positive BINX write-up. Pop tomorrow Mel Spivak-2/1/1998
93 ------------------------------------------------------------------------ WednesJames Baker-1/17/1998
92 Sorry I haven't got any info yet. I'm in the process of getting a compSparticus-1/6/1998
91 Howard, Are you still with us? I assume that you saw H&Q lowered their estJames Baker-1/3/1998
90 Howard, How ya doin', haven't heard from ya in a while. I dont want tSparticus-12/16/1997
89 I'm not familiar w/ it. I'll do some research and get back to ya thougSparticus-12/11/1997
88 Any comments on U.S. Surgical's meniscus staple device?Jim Mac-12/11/1997
87 James, I must admit, I haven't charted BINX in a while, so this is just offHoward-11/20/1997
86 BINX off with most of the biotech market today. Did anyone see any BINX specifJames Baker-11/19/1997
85 John - I posted part of IBD's "New America" article a few days agStephen D. French-10/9/1997
84 I can only hope my BINX position does as well as my BIOX has! Stay tuned for thjohn robinson-10/8/1997
83 John, It's not only the method of choice in Canada. Myslef and alot of my Howard-10/8/1997
82 That would be great if you could post the article. The " Arrow" devicjohn robinson-10/7/1997
81 Yes - excellent move upwards. I learned of this company from reading IBD's Stephen D. French-10/7/1997
80 Obviously a beautiul move today. Up 4 is always a good thing. Let's hope Howard-10/6/1997
79 First call has est of 0.05 and 0.10 for the next two quarters and 0.21 for the James Baker-10/4/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):